Correction to: A real‑world experience of eltrombopag plus rabbit antithymocyte immunoglobulin-based IST in Chinese patients with severe aplastic anemia
Ann Hematol. 2023 Feb;102(2):501.
doi: 10.1007/s00277-023-05107-7.
1 Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, 300 Guangzhou Road, Nanjing, Jiangsu, People's Republic of China.
2 Department of Hematology, Zhejiang Province Hospital of TCM, The First Affiliated Hospital of Zhejiang TCM University, Hangzhou, China.
3 Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, 11# Xizhimen South Street, Beijing, 100044, China.
4 Department of Tumor and Hematology, The First Hospital of Jilin University, Changchun, 130021, China.
5 Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
6 Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, 300 Guangzhou Road, Nanjing, Jiangsu, People's Republic of China. heguangsheng1972@sina.com.